Geneos Wealth Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.3M | Sell |
29,877
-23,610
| -44% | -$5.5M | 0.17% | 146 |
|
|
2025
Q4 | $11.1M | Sell |
53,487
-890
| -2% | -$176K | 0.27% | 86 |
|
|
2025
Q3 | $10.1M | Sell |
54,377
-2,639
| -5% | -$452K | 0.26% | 92 |
|
|
2025
Q2 | $8.71M | Sell |
57,016
-87,919
| -61% | -$13.5M | 0.21% | 121 |
|
|
2025
Q1 | $25.1M | Buy |
144,935
+82,943
| +134% | +$13M | 0.36% | 62 |
|
|
2024
Q4 | $8.97M | Buy |
61,992
+1,113
| +2% | +$172K | 0.31% | 68 |
|
|
2024
Q3 | $9.87M | Buy |
60,879
+6,303
| +12% | +$1M | 0.38% | 57 |
|
|
2024
Q2 | $7.98M | Buy |
54,576
+19,144
| +54% | +$2.85M | 0.35% | 61 |
|
|
2024
Q1 | $5.6M | Sell |
35,432
-464
| -1% | -$73.9K | 0.26% | 90 |
|
|
2023
Q4 | $5.63M | Sell |
35,896
-1,074
| -3% | -$165K | 0.28% | 87 |
|
|
2023
Q3 | $5.76M | Buy |
36,970
+1,448
| +4% | +$239K | 0.3% | 81 |
|
|
2023
Q2 | $5.88M | Buy |
35,522
+1,619
| +5% | +$261K | 0.31% | 76 |
|
|
2023
Q1 | $5.26M | Sell |
33,903
-3,077
| -8% | -$497K | 0.32% | 76 |
|
|
2022
Q4 | $6.53M | Buy |
36,980
+798
| +2% | +$138K | 0.4% | 54 |
|
|
2022
Q3 | $5.91M | Sell |
36,182
-27,178
| -43% | -$4.6M | 0.41% | 48 |
|
|
2022
Q2 | $11.4M | Buy |
63,360
+3,291
| +5% | +$586K | 0.56% | 35 |
|
|
2022
Q1 | $10.6M | Sell |
60,069
-5,230
| -8% | -$890K | 0.46% | 40 |
|
|
2021
Q4 | $11.2M | Sell |
65,299
-540
| -0.8% | -$88.4K | 0.43% | 46 |
|
|
2021
Q3 | $10.6M | Sell |
65,839
-4,528
| -6% | -$773K | 0.4% | 51 |
|
|
2021
Q2 | $11.9M | Sell |
70,367
-5,805
| -8% | -$961K | 0.46% | 43 |
|
|
2021
Q1 | $12.4M | Sell |
76,172
-5,636
| -7% | -$912K | 0.35% | 69 |
|
|
2020
Q4 | $12.4M | Buy |
81,808
+7,632
| +10% | +$1.13M | 0.5% | 42 |
|
|
2020
Q3 | $10.8M | Sell |
74,176
-329
| -0.4% | -$48.7K | 0.56% | 34 |
|
|
2020
Q2 | $10.3M | Buy |
74,505
+4,226
| +6% | +$616K | 0.57% | 32 |
|
|
2020
Q1 | $8.66M | Sell |
70,279
-773
| -1% | -$110K | 0.58% | 29 |
|
|
2019
Q4 | $10.4M | Buy |
71,052
+441
| +0.6% | +$59.8K | 0.55% | 31 |
|
|
2019
Q3 | $9.08M | Sell |
70,611
-39
| -0.1% | -$5.14K | 0.54% | 37 |
|
|
2019
Q2 | $9.85M | Sell |
70,650
-810
| -1% | -$112K | 0.61% | 27 |
|
|
2019
Q1 | $9.99M | Buy |
71,460
+3,081
| +5% | +$413K | 0.66% | 24 |
|
|
2018
Q4 | $8.71M | Buy |
68,379
+989
| +1% | +$138K | 0.64% | 26 |
|
|
2018
Q3 | $9.32M | Buy |
67,390
+4,544
| +7% | +$604K | 0.62% | 24 |
|
|
2018
Q2 | $7.63M | Sell |
62,846
-7,505
| -11% | -$936K | 0.59% | 33 |
|
|
2018
Q1 | $9.02M | Sell |
70,351
-1,283
| -2% | -$173K | 0.79% | 18 |
|
|
2017
Q4 | $10M | Buy |
71,634
+1,542
| +2% | +$215K | 0.89% | 12 |
|
|
2017
Q3 | $9.11M | Buy |
70,092
+2,760
| +4% | +$366K | 0.91% | 12 |
|
|
2017
Q2 | $8.91M | Buy |
67,332
+3,440
| +5% | +$439K | 0.91% | 13 |
|
|
2017
Q1 | $7.96M | Buy |
63,892
+2,325
| +4% | +$278K | 0.83% | 19 |
|
|
2016
Q4 | $7.09M | Buy |
61,567
+787
| +1% | +$90.9K | 0.94% | 15 |
|
|
2016
Q3 | $7.18M | Sell |
60,780
-207
| -0.3% | -$25.1K | 0.97% | 16 |
|
|
2016
Q2 | $7.4M | Buy |
60,987
+576
| +1% | +$65.5K | 1.07% | 12 |
|
|
2016
Q1 | $6.6M | Buy |
+60,411
| New | +$6.25M | 1.01% | 17 |
|
Other funds holding JNJ
VCM
VPM
Geneos Wealth Management's JNJ Position: Q1 2026 in Review
Geneos Wealth Management reduced its Johnson & Johnson (JNJ) stake by 44% in Q1 2026, selling an estimated $5.5M and leaving 29,877 shares worth $7.3M. The position accounts for 0.17% of the portfolio, ranked #146.
Geneos Wealth Management first reported a position in JNJ in Q1 2016 and has held it in 41 quarters since. The position peaked at $25.1M in Q1 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Geneos Wealth Management held 29,877 shares of Johnson & Johnson worth $7.3M as of Q1 2026.
- Geneos Wealth Management sold 23,610 Johnson & Johnson shares in Q1 2026, an estimated $5.5M.
- Johnson & Johnson made up 0.17% of Geneos Wealth Management's portfolio in Q1 2026, its #146 holding.
- Geneos Wealth Management first reported a position in Johnson & Johnson in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Johnson & Johnson position peaked at $25.1M in Q1 2025.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.